发明申请
- 专利标题: GENETIC COMPONENT OF COMPLICATIONS IN TYPE 2 DIABETES
- 专利标题(中): 2型糖尿病合并基因组成
-
申请号: US12997621申请日: 2009-06-15
-
公开(公告)号: US20110158979A1公开(公告)日: 2011-06-30
- 发明人: Pavel Hamet , Johanne Tremblay , Ondrej Seda , Stephen Macmahon , John Chalmers
- 申请人: Pavel Hamet , Johanne Tremblay , Ondrej Seda , Stephen Macmahon , John Chalmers
- 申请人地址: CA Montreal
- 专利权人: PROGNOMIX, INC.
- 当前专利权人: PROGNOMIX, INC.
- 当前专利权人地址: CA Montreal
- 国际申请: PCT/IB2009/006638 WO 20090615
- 主分类号: A61K39/395
- IPC分类号: A61K39/395 ; C12Q1/68 ; C40B30/00 ; C40B40/06 ; A61K31/7105 ; A61P3/10
摘要:
The invention provides with means to predict, in subjects affected by type 2 diabetes (T2D), the probability of developing complications related to the disease. The invention involves 1) use of genetic features (SNPs, STRs, or other genomic markers) together with other chromosomal features and phenotypic information to establish a patient profile specifically developed for prediction of complications of T2D 2) use of a set of SNPs allowing to discriminate between individuals according to their descent. The invention also provides with methods for characterizing and selecting, within a population of subjects with type-2 diabetes, subjects that are suited for clinical trials based on the identification of one or more genetic features. Also described are combinations and kits for carrying out the above-described methods.